corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 19239

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: Journal Article

Hawkes N
Companies that want to charge a higher than basic price for a new drug will have to give evidence that it’s worth it
BMJ 2010 Dec 20; 341:
http://www.bmj.com/content/341/bmj.c7296.extract


Abstract:

A clearer picture of the UK government’s plans for value based pricing of drugs has emerged from a consultation paper published this week.

The new system, to be introduced at the beginning of 2014, aims to price drugs according to the value they deliver to patients. It will apply only to new branded drugs, not to generics or drugs already on the market, and will provide a series of maximum prices that depend on the burden of illness treated, the wider social impacts of a new treatment, and whether the product breaks new ground.

The basic price (confusingly called a “threshold” in the paper) of all new drugs will be calculated on the basis of other services that will be displaced elsewhere in the NHS if the new treatment is to be paid for—but the paper does not specify how costs will be compared. It does …

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








Far too large a section of the treatment of disease is to-day controlled by the big manufacturing pharmacists, who have enslaved us in a plausible pseudo-science...
The blind faith which some men have in medicines illustrates too often the greatest of all human capacities - the capacity for self deception...
Some one will say, Is this all your science has to tell us? Is this the outcome of decades of good clinical work, of patient study of the disease, of anxious trial in such good faith of so many drugs? Give us back the childlike trust of the fathers in antimony and in the lancet rather than this cold nihilism. Not at all! Let us accept the truth, however unpleasant it may be, and with the death rate staring us in the face, let us not be deceived with vain fancies...
we need a stern, iconoclastic spirit which leads, not to nihilism, but to an active skepticism - not the passive skepticism, born of despair, but the active skepticism born of a knowledge that recognizes its limitations and knows full well that only in this attitude of mind can true progress be made.
- William Osler 1909